The Sarah Cannon Transplant and Cellular Therapy Program at Las Vegas-based Sunrise Health’s MountainView Hospital has opened an outpatient facility to provide advanced blood cancer care. The Day Hospital, located on the MountainView Hospital campus, houses six exam rooms, six…
Oncology
Burlington, Mass.-based Tufts Medicine has tapped Don Dizon, MD, as system chief of hematology-oncology for the cancer service line for Tufts Medicine. Dr. Dizon has also been named the Jane F. Desforges, MD, Chair in Hematology and Oncology at Tufts…
Data science and AI continue to make healthcare headlines because of their potential to change everything from how drugs are developed to revolutionizing information workflows. One area where we anticipate opportunities for significant impact is in the field of operations…
The National Comprehensive Cancer Network, a coalition of 33 leading U.S. cancer centers, has rolled out a digital navigator for its clinical practice guidelines. The new tool delivers frequently updated cancer care guidelines on an interactive, virtual platform, according to…
Danville, Pa.-based Geisinger has implemented a systemwide expansion of 3D mammography. In a recent study, 3D mammography had a higher rate of cancer depiction compared to traditional mammography. The technology may also reduce the need for additional imaging and minimize…
Advertisement
Phoenix-based Mayo Clinic in Arizona has added lung transplantation to its solid organ transplant program. A surgical team led by Jonathan D’Cunha, MD, PhD, surgical director of the Mayo Clinic in Arizona Lung Transplant Program, performed the first lung transplant…
Orange, Calif.-based UCI Health has tapped Gary Deng, MD, PhD, to serve as director of the Integrative Oncology program at the UCI Health Chao Family Comprehensive Cancer Center. Dr. Deng was also appointed associate director of the cancer center and…
Researchers from West Orange, N.J.-based RWJBarnabas Health, New Brunswick, N.J.-based Rutgers Cancer Institute, Boston-based Tufts Medical Center and the University of Manchester in England, have developed a risk prediction model for early-stage classic Hodgkin lymphoma. The model is called the…
An Orlando, Fla.-based Advent Health surgeon has performed a prostatectomy via transcontinental robotic telesurgery — the first of an FDA-approved clinical trial to test the technology, according to a June 17 ABC News report. The patient lives in the nation…
As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind immunotherapy response and resistance. Here are three recent immunotherapy research initiatives: